Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?
Acta Ophthalmologica · 2025
DOI: 10.1111/aos.17498 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Mark J N Buijs und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Section Ophthalmogenetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Gyrate Atrophy, Ornithine-Oxo-Acid Transaminase, Retinal Pigment Epithelium, Retina. Die Arbeit nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Emma Children Hospital Support Foundation Grant, Stichting Metakids, Stichting voor Ooglijders.
Abstract (Originalsprache)
Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase ( OAT ) resulting in hyperornithinaemia. Clinically, GACR is characterized by the concentric loss of visual fields due to progressive chorioretinal atrophy. Because OAT is systemically expressed, it is not clear why primarily the retina is damaged in GACR patients. In this review, we first provide an extensive overview of the clinical features and current treatment modalities for GACR. Next, we discuss the different pathways involved in ornithine metabolism, including the urea cycle, polyamine synthesis, creatine synthesis, proline synthesis and degradation and provide our vision on how OAT deficiency is thought to affect these pathways in the retinal pigment epithelium (RPE). We provide several hypotheses to explain the retinal pathology observed in GACR and discuss perspectives on future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Section Ophthalmogenetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
- United for Metabolic Diseases, Amsterdam, The Netherlands.
- Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Mark J N Buijs, Berith M Balfoort, Camiel J F Boon, Roselie M H Diederen
Förderung
- Emma Children Hospital Support Foundation Grant
- Stichting Metakids
- Stichting voor Ooglijders
- Stichting Zeldzame Ziekten Fonds
- The Horstingstuit Foundation
Zitieren
APA
Buijs, M. J. N., Balfoort, B. M., Brands, M. M., Ten Asbroek, A. L. M. A., Boon, C. J. F., Diederen, R. M. H., Timmer, C., Wagenmakers, M. A. E. M., Waterham, H. R., Wanders, R. J. A., Houtkooper, R. H., van Karnebeek, C. D., & Bergen, A. A. (2025). Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?. Acta Ophthalmologica. https://doi.org/10.1111/aos.17498
Vancouver
Buijs MJN, Balfoort BM, Brands MM, Ten Asbroek ALMA, Boon CJF, Diederen RMH, et al. Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?. Acta Ophthalmologica. 2025. doi:10.1111/aos.17498
BibTeX
@article{Buijs2025,
author = {Buijs, Mark J N and Balfoort, Berith M and Brands, Marion M and Ten Asbroek, Anneloor L M A and Boon, Camiel J F and Diederen, Roselie M H and Timmer, Corrie and Wagenmakers, Margreet A E M and Waterham, Hans R and Wanders, Ronald J A and Houtkooper, Riekelt H and van Karnebeek, Clara D and Bergen, Arthur A},
title = {Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?},
journal = {Acta Ophthalmologica},
year = {2025},
doi = {10.1111/aos.17498}
}
EUVIMED